Inozyme Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Inozyme Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About INZY

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. 

CEO
Doug Treco Treco, PhD
CEODoug Treco Treco, PhD
Employees
67
Employees67
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2015
Founded2015
Employees
67
Employees67

INZY Key Statistics

Market cap
257.88M
Market cap257.88M
Price-Earnings ratio
-2.38
Price-Earnings ratio-2.38
Dividend yield
Dividend yield
Average volume
712.81K
Average volume712.81K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.24
52 Week high$6.24
52 Week low
$0.721
52 Week low$0.721

Stock Snapshot

With a market cap of 257.88M, Inozyme Pharma(INZY) trades at $4.00. The stock has a price-to-earnings ratio of -2.38.

Inozyme Pharma(INZY) stock opened on 2026-01-26 at —. The price climbed to — and dipped to —.

The Inozyme Pharma(INZY)'s current trading volume is 0, compared to an average daily volume of 712.81K.

During the past year, Inozyme Pharma(INZY) stock moved between $0.72 at its lowest and $6.24 at its peak.

During the past year, Inozyme Pharma(INZY) stock moved between $0.72 at its lowest and $6.24 at its peak.

People also own

Based on the portfolios of people who own INZY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.